Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 11/25 09:32:56 am
7861 GBX   -1.74%
08:15aASTRAZENECA : New Covid-19 Vaccines Stir Hope for the World's Poor
DJ
08:11aDow's Rise to 30000 Heralds a Broader Stock Rally
DJ
07:23aDow's Rise to 30000 Heralds a Broader Stock Rally
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

J&J, AstraZeneca resuming trials of vaccines

10/24/2020 | 04:34pm EST

Two trials involving coronavirus vaccine candidates are resuming. AstraZeneca has restarted the U.S. trial of its experimental COVID-19 vaccine, and Johnson & Johnson is set to resume its trial on Monday or Tuesday.

AstraZeneca said Friday the U.S. Food and Drug Administration has deemed it safe to continue testing the vaccine. The company had to pause its U.S. trial last month after a report of a serious neurological illness in a participant in its trial in the UK.It is developing its vaccine with researchers at Oxford University.

Johnson & Johnson said Friday that the independent safety panel, the Data and Safety Monitoring Board, has recommended that it resume trial recruitment after finding no evidence that the vaccine caused a volunteer to fall ill. The company says it's on track to produce trial data of the vaccines' effectiveness by the end of this year or early 2021.

Both companies have contracts to supply vaccines to the U.S. and other governments if they are cleared by regulators.


© Reuters 2020
All news about ASTRAZENECA PLC
08:15aASTRAZENECA : New Covid-19 Vaccines Stir Hope for the World's Poor
DJ
08:11aDow's Rise to 30000 Heralds a Broader Stock Rally
DJ
07:23aDow's Rise to 30000 Heralds a Broader Stock Rally
DJ
06:06aEXPLAINER : When and how will COVID-19 vaccines become available?
RE
05:45aDow's Rise to 30000 Heralds a Broader Stock Rally
DJ
04:40aASTRAZENECA : Lokelma label update approved in China for patients with hyperkala..
AQ
02:37aFLIRTING WITH RECORD HIGHS : European stocks back to normal in 2021 - Reuters po..
RE
01:16aNEWS HIGHLIGHTS : Top Company News of the Day
DJ
11/24ANALYSIS : Dow cracks 30,000, a psychological boost during a pandemic
RE
11/24Copper near 7-year high on Biden transition, vaccine hopes, low China stocks
RE
More news
Financials (USD)
Sales 2020 26 523 M - -
Net income 2020 3 016 M - -
Net Debt 2020 13 181 M - -
P/E ratio 2020 47,9x
Yield 2020 2,63%
Capitalization 140 B 140 B -
EV / Sales 2020 5,79x
EV / Sales 2021 5,04x
Nbr of Employees 70 600
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 121,48 $
Last Close Price 106,90 $
Spread / Highest target 45,4%
Spread / Average Target 13,6%
Spread / Lowest Target -38,3%
EPS Revisions
Managers
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC5.17%140 189
JOHNSON & JOHNSON-1.37%378 744
ROCHE HOLDING AG-4.28%281 946
PFIZER INC.-6.59%203 437
MERCK & CO., INC.-11.89%202 757
NOVARTIS AG-12.66%200 273